5 results match your criteria: "The St. Laurent Institute[Affiliation]"
Front Cardiovasc Med
June 2024
Department of Medicine, Division of Genomic Medicine, The George Washington University, Washington, DC, United States.
Background: Ischemia with non-obstructive coronary arteries (INOCA) is a major clinical entity that involves potentially 20%-30% of patients with chest pain. INOCA is typically attributed either to coronary microvascular disease and/or vasospasm, but is likely distinct from classical coronary artery disease (CAD).
Objectives: To gain insights into the etiology of INOCA and CAD, RNA sequencing of whole blood from patients undergoing both stress testing and elective invasive coronary angiography (ICA) was conducted.
J Mol Cell Cardiol Plus
June 2023
The St. Laurent Institute, 317 New Boston Street, Woburn, MA 01801, United States of America.
Background: Cardiovascular disease had a global prevalence of 523 million cases and 18.6 million deaths in 2019. The current standard for diagnosing coronary artery disease (CAD) is coronary angiography either by invasive catheterization (ICA) or computed tomography (CTA).
View Article and Find Full Text PDFBMC Genomics
November 2021
Department of Medicine, Division of Genomic Medicine, The George Washington University Medical Center, 2300 Eye St, Washington D.C, 20037, USA.
Background: Despite proven therapeutic effects in inflammatory conditions, the specific mechanisms of phytochemical therapies are not well understood. The transcriptome effects of Traumeel (Tr14), a multicomponent natural product, and diclofenac, a non-selective cyclooxygenase (COX) inhibitor, were compared in a mouse cutaneous wound healing model to identify both known and novel pathways for the anti-inflammatory effect of plant-derived natural products.
Methods: Skin samples from abraded mice were analyzed by single-molecule, amplification-free RNAseq transcript profiling at 7 points between 12 and 192 h after injury.
BMC Med Genomics
September 2021
The St. Laurent Institute, Vancouver, WA, USA.
Background: Cardiovascular disease had a global prevalence of 523 million cases and 18.6 million deaths in 2019. The current standard for diagnosing coronary artery disease (CAD) is coronary angiography.
View Article and Find Full Text PDFBMC Med Genomics
October 2020
Oregon Health and Science University, Portland, OR, USA.